Veligrotug BLA accepted for thyroid eye disease (TED) with PDUFA target action date of June 30, 2026 under Priority Review; commercial preparations on track -- Topline phase 3 results for subcutaneous ...
The positive interim results of the Phase 1a SAD/MAD trial support rapid advancement of clinical development. Aclaris expects to initiate a Phase 1b POC trial in AD imminently and a Phase 1b POC trial ...
AMD confirms its next-gen Instinct MI500 AI accelerator fabbed on TSMC 2nm process, next-gen HBM4E memory, and next-gen CDNA ...
Oruka analysis: ultra-durable psoriasis biologics ORKA-001/002 aim for 1–3 doses/yr with strong efficacy; liquid balance ...
Hrithik Roshan dances with sons Hrehaan, Hridhaan at cousin Eshaan’s wedding; epic Roshan family pic goes viral: 'Will pay to ...
KIOXIA is once again at CES 2026 and it will be showcasing how it's 'flash solutions touch virtually every corner of modern ...
The Truth About 'Healthy' Smokers and Drinkers: Dr. Pravin Kahale Explains | N18S What is the meaning of "i" in iPhone, iPad, ...
JADE101 Phase 1 healthy volunteer trial ongoing; biomarker-rich interim data expected in the first half of 2026 Phase 2 clinical trial of JADE101 ...
Ninth place went to the huge mod Horn of the Abyss for Heroes of Might and Magic III. In practice, it is an unofficial ...
Spyre Therapeutics (SYRE) stock analysis: de-risked pipeline, cash runway to H2 2028, and 2026–2027 Phase 2 catalysts in ...